|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/05 | (2006.01) |
| A61K 31/05 | (2013.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61P 25/08 | (2018.01) |
| (11) | Number of the document | 4061344 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20815902.0 |
| Date of filing the European patent application | 2020-11-18 | |
| (97) | Date of publication of the European application | 2022-09-28 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2020/052942 |
| Date | 2020-11-18 |
| (87) | Number | WO 2021/099781 |
| Date | 2021-05-27 |
| (30) | Number | Date | Country code |
| 201916974 | 2019-11-21 | GB |
| (72) |
GUY, Geoffrey , GB
KNAPPERTZ, Volker , GB
WHALLEY, Benjamin , GB
WOOLLEY-ROBERTS, Marie , GB
|
| (73) |
GW Research Limited ,
Sovereign House Vision Park
Chivers Way
Histon, Cambridge, Cambridgeshire CB24 9BZ,
GB
|
| (54) | 6-HYDROXY CANNABIDIOL FOR USE AS A MEDICAMENT |
| 6-HYDROXY CANNABIDIOL FOR USE AS A MEDICAMENT |